Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

Dow:

Nasdaq:

S&P 500:

AMRX

$21.510.75%0.16

Dopo l'orario di chiusura: 21.48-0.03 -0.14%

Amneal Pharmaceuticals Inc (AMRX)

Date: O: H: L: C: Vol:

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

GILD Beats Q3 Earnings on HIV Strength & Trodelvy Sales Growth - Zacks Investment Research

INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised Guidance - Zacks Investment Research

VKTX Q3 Earnings Miss Estimates Amid Rising Clinical Expenses - Zacks Investment Research

Amarin's Q3 Earnings Beat Estimates, Revenues Miss Mark - Zacks Investment Research

BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises - Zacks Investment Research

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Zacks Investment Research

Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy? - Zacks Investment Research

Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research

Parabilis Medicines, Inc. (PBLS) Stock Price & News - Syfe

Curis raises $8.5M via stock and warrant sale t... - Pluang

KNSA Stock Price, Quote & News - Syfe

Generate Biomedicines, Inc. (GENB) Stock Price & News - Syfe

Ionis Pharmaceuticals, Inc. (IONS) Stock Price & News - Syfe

LGND Stock Price, Quote & News - Syfe

Liquidia Corporation (LQDA) Stock Price & News - Syfe

Form 4 Amneal Pharmaceuticals Inc Class A For: 23 September By Investing.com - Investing.com Canada

Form 4 Amneal Pharmaceuticals Inc Class A For: 23 September By Investing.com - Investing.com UK

Form 4 Amneal Pharmaceuticals Inc Class A For: 22 September By Investing.com - Investing.com Nigeria

Form 4 Amneal Pharmaceuticals Inc Class A For: 22 September By Investing.com - Investing.com UK

Form 4 Amneal Pharmaceuticals Inc Class A For: 22 September By Investing.com - Investing.com Canada

Amneal Pharmaceuticals Director Kevin J. Buchi Transfers 20,445 Shares to Trust - Kalkine Media

Amneal (NASDAQ: AMRX) director gifts 20,445 shares to trust he oversees - Stock Titan

Kentucky Gov. Andy Beshear visits Amneal's Glasgow facility - goSkagit

Kentucky Gov. Andy Beshear visits Amneal's Glasgow facility - postregister.com

Amneal Pharmaceuticals, Inc. - Class A Common Stock (NQ: AMRX - The Chronicle-Journal

Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target - marketscreener.com

Bausch Health Companies Inc (BHC) Stock Price & News - Syfe

Does Amneal’s New US$523 Million Shelf Registration Reframe Its Capital Allocation Story for AMRX? - simplywall.st

Does Amneal’s New US$523 Million Shelf Registration Reframe Its Capital Allocation Story for AMRX? - simplywall.st

Does Amneal’s Post‑Earnings Shelf Registration Reshape the Bull Case for Amneal Pharmaceuticals (AMRX)? - Yahoo Finance

Amneal Pharmaceuticals (AMRX) Bets Big On Biosimilars While Wall Street Retreats - Yahoo Finance

Amneal Pharmaceuticals (AMRX) Stock Sees Modest Fair Value Lift On Launch Optimism - Yahoo Finance

US FDA is working with manufacturers to boost estrogen patch supply amid access concerns - Reuters

Amneal Pharmaceuticals files prospectus for sale of up to 28.9 million shares - scanx.trade

Amneal Pharmaceuticals (AMRX) Following Its Biosimilars Push And The Fair Value Debate - simplywall.st

Generic Pharmaceuticals Stocks Q2 Results: Benchmarking Amneal (NASDAQ:AMRX) - Yahoo Finance

Amneal Pharmaceuticals Says US FDA Approves Romidepsin Injection Solution - Moomoo

ZLAB Stock Price, Quote & News - Syfe

Parabilis Medicines, Inc. (PBLS) Stock Price & News - Syfe

J.P. Morgan Maintains Amneal Pharmaceuticals(AMRX.US) With Buy Rating, Raises Target Price to $22 - Moomoo

Amneal builds end-to-end biosimilars capacity in the U.S. - chaindrugreview.com

Amneal Pharmaceuticals (AMRX) Stock Looks Fairly Valued But Earnings Still Look Rich - sahmcapital.com

Amneal (AMRX) Results Review: Profit Per Share Clears Its Benchmark in Latest Trading; Closing Reaction: The Share Price Adds 1.87% in the Current Update - Profit Warning Alert - vinanet.vn

Amneal (AMRX) Earnings Report: EPS Beats Its Estimate in Latest Trading; The Market Price Declines 1.25% in the Latest Session - Diluted EPS Report - vinanet.vn

STOCK ALERT: Kaskela Law Announces Shareholder Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages Current AMRX Stockholders to Contact the Firm - Business Wire

Zacks.com featured highlights include CareDx, Healthcare Services, Forum Energy Tech, Amneal Pharma and Caterpillar - Yahoo Finance

Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance - Sahm

Is Amneal Pharmaceuticals (AMRX) Fairly Valued After A 3.5x Return? - Yahoo Finance

AMRX Q2 2026 Earnings: Strong EPS Beat Drives 5.1% Rally - Earnings Revision Upgrade - vinanet.vn

Amneal Pharmaceuticals Director John Kiely Sells 50,000 Shares and Donates 10,000 Shares on August 13, 2026 - Kalkine Media

Simile a AMRX

ALKS$45.340.07%

KNSA$92.245.45%

LNTH$100.460.14%

HIMS$27.686.71%

INDV$35.370.34%

LQDA$45.060.16%